Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03623607 · ClinicalTrials.gov registry record
Diabetes to Go: Inpatient Education Implementation
A clinical trial, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- 596
- Enrollment target
NCT03623607: Completed study, sponsored by Medstar Health Research Institute.
NCT03623607 is a clinical trial that has completed, run by Medstar Health Research Institute. The registered enrollment target is 596 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03623607 has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- 596 participants
- Enrollment target
Study Summary
The study used the Practical, Robust, Implementation and Sustainability Model (PRISM) with mixed methods to: redesign a diabetes survival skills education (DSSE) program (DM2Go) content and the processes for its inpatient delivery; and to evaluate the feasibility of integrating and implementing high-tech tablet computer-enabled delivery of the DSSE program for hospital inpatients within usual workflow by staff on general medical/surgical units (MSUs) and a behavioral health unit. The four study phases were: I) Interviews and focus groups with stakeholders to identify perceived barriers and facilitators for implementation; II) Redesign of the D2Go program to address usability issues and potential barriers and to optimize perceived facilitators; III) Development of implementation processes and a D2Go toolkit; IV) Conduct of a prospective cohort pilot study on three MSUs and one BHU.
Primary Outcome
To identify and validate barriers and facilitators of reach, effectiveness, adoption, implementation and maintenance of a diabetes survival skills education program which is delivered at the bedside using a web-based e-learning platform by nursing unit staff to adult patients with type 2 diabetes prior to discharge from the hospital. Nursing unit staff (RN, patient care technician, clerical, leadership) provided input via focus groups and key informant interviews to inform intervention design.
Interventions
- OTHER Diabetes Survival Skills Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 596 participants |
| Start Date | 2016-04-01 |
| Est. Completion | 2019-03-31 |
What the finished NCT03623607 record still lists
NCT03623607 is an observational study that tracks outcomes without assigning an intervention. The registered 596 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Diabetes Survival Skills Education is the first listed.
NCT03623607 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03623607 about?
NCT03623607 is a clinical study titled "Diabetes to Go: Inpatient Education Implementation". The study used the Practical, Robust, Implementation and Sustainability Model (PRISM) with mixed methods to: redesign a diabetes survival skills education (DSSE) program (DM2Go) content and the processes for its inpatient delivery; and to evaluate the feasibility of integrating and implementing high...
What is the current status of trial NCT03623607?
This trial is currently completed. The enrollment target is 596 participants. The study started on 2016-04-01. Estimated completion is 2019-03-31.
What interventions are being tested in trial NCT03623607?
The interventions under investigation include: Diabetes Survival Skills Education (OTHER).
Who is sponsoring clinical trial NCT03623607?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02138734 · 596 participants · Phase 1
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer
- NCT06797245 · 596 participants · NA
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
- NCT07100080 · 596 participants · Phase 2
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
- NCT05723198 · 595 participants · Phase 3
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI